# Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms

> **NCT04368819** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Ministry of Health, Brazil** · enrollment: 40 (estimated)

## Conditions studied

- Refractory Angina

## Interventions

- **DRUG:** Allopurinol 300 MG
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04368819
- **Lead sponsor:** Ministry of Health, Brazil
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-03
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-02-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04368819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04368819, "Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04368819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*